AI-generated analysis. Always verify with the original filing.
Xenon Pharmaceuticals Inc. announced its 2026 annual meeting, record date, and certain other information on March 13, 2026. This disclosure under Item 8.01 provides shareholders with key details for participating in the annual meeting.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On March 13, 2026, Xenon Pharmaceuticals Inc. announced the meeting, record date and certain other information relating to its 2026 annual meeting
Financial Statements and Exhibits (d) Exhibits. Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed